Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: The heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism

Fertility and Sterility

Volumn 71, Issue 1, 1999, Pages 115-121

  Villa, Paola ^a   Valle, Domenico ^a   Mancini, Antonio ^a   De Marinis, Laura ^a   Pavone, Virginia ^a   Fulghesu, Anna Maria ^a   Mancuso, Salvatore ^a   Lanzone, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Growth hormone; Insulin; Obesity; Opioids; Polycystic ovary syndrome

Indexed keywords

GLUCOSE; GONADOTROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; NALTREXONE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; STEROID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYPERINSULINISM; INSULIN BLOOD LEVEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; AREA UNDER CURVE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; HYPERINSULINISM; INSULIN; NALTREXONE; NARCOTIC ANTAGONISTS; OBESITY; POLYCYSTIC OVARY SYNDROME;

EID: 0032894725     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00405-1     Document Type: Article

References (24)

1. Goldzieher J.W. Polycystic ovarian disease. Fertil Steril. 35:1981;371-394.
2. Lanzone A., Villa P., Fulghesu A.M., Pavone V., Caruso A., Mancuso S. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome relationship with obesity and hyperinsulinemia . Hum Reprod. 10:1995;1653-1657.
3. Lee E.J., Park K.H., Lee B.S., Song C.H., Lee M.C., Huh K.B. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome. Fertil Steril. 660:1993;53-57.
4. Kazer R.R., Untermann T.G., Glick P.P. An abnormality of the growth hormone/insulin-like growth factor-1 axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 71:1990;958-962.
5. Williams T., Berelowitz M., Joffe S., Thorner M.O., Rivier J., Vale W., et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. N Engl J Med. 311:1984;1403-1407.
6. Katz E., Ricciarelli E., Adashi E.Y. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril. 59:1993;8-34.
7. Bruni J., Watkins W., Yen S.S.C. B-endorphin in the human pancreas. J Clin Endocrinol Metab. 49:1979;649-651.
8. Givens J.R., Wiedeman E., Andersen R.M., Kitabchi A.E. Beta-endorphin and b-lipotrophin plasma levels in hirsute women correlation with body weight . J Clin Endocrinol Metab. 50:1980;975-976.
9. Fulghesu A.M., Lanzone A., Cucinelli F., Caruso A., Mancuso S. Long term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovarian disease. Obstet Gynecol. 82:1993;191-197.
10. De Marinis L., Folli G., D'Amico C., Mancini A., Sambo P., Tofani A., et al. Differential effects of feeding on the ultradian variation of the growth hormone response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa. J Clin Endocrinol Metab. 66:1988;598-604.
11. De Marinis L., Mancini A., Folli G., D'Amico C., Corsello S., Sciuto R., et al. Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity. Neuroendocrinology. 50:1989;529-532.
12. New M.I., Lorenzen F., Lerner A.J., Kohn B., Oberfield S.E., Pollack M.S., et al. Genotyping steroid 21-hydroxylase deficiency hormonal reference data . J Clin Endocrinol Metab. 57:1983;320-326.
13. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1979;1039-1057.
14. Lanzone A., Fulghesu A.M., Fortini A., Cutillo G., Cucinelli F., Di Simone N., et al. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. Hum Reprod. 6:1991;1043-1049.
15. Pfeiffer A., Hertz A. Endocrine actions of opioids. Horm Metab Res. 16:1984;387-397.
16. Du Pont A., Cusan L., Garon M. β-Endorphin stimulation of growth hormone release in vivo. Proc Natl Acad Sci U S A. 74:1977;358-359.
17. Grossman A., Stubbs W.A., Gailland R.C., Delitala G., Rees L.H., Besser G.M. Studies of the opiate control of prolactin, GH, and TSH. Clin Endocrinol (Oxf). 14:1981;381-386.
18. Wehremberg W., Block B., Ling N. Pituitary secretion of growth hormone in response to opioid peptides and opiates is mediated through growth hormone-releasing factor. Neuroendocrinology. 41:1985;13-16.
19. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1981;1279-1281.
20. Slowinska-Srzednicka J., Zgliczynski W., Marowska A., Jeske W., Brezezinska A., Soszynsky P., et al. An abnormality of the growth hormone/insulin-like growth factor-1 axis in women with polycystic ovary syndrome due to coexistent obesity. J Clin Endocrinol Metab. 74:1992;1432-1435.
21. Morales A.J., Laughlin G.A., Butzow T., Maheshwari H. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome common and distinct features . J Clin Endocrinol Metab. 81:1996;2854-2864.
22. Micic D., Kendereski A., Popovic V., Sumarac M., Zoric S., Macult D., et al. Growth hormone response to GHRH, GHRP-6 and GHRH+GHRP-6 in patients with polycystic ovary syndrome. Clin Endocrinol. 45:1996;385-390.
23. Piaditis G.P., Kounadi D., Rangou D.B., Trovas G.P., Kaklas N.A., Tzonou A.J., et al. Dysfunction of the growth hormone/insulin-like growth factor-1 axis in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 42:1995;635-640.
24. Morris R.S., Carmina E., Vijod M.A., Stanczyk K.Z., Lobo R.A. Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome. Fertil Steril. 63:1995;742-746.